Effects of intravenous magnesium sulphate in acute myocardial infarction.
This column reviews the results of second Leicester Intravenous Magnesium Sulphate Intervention Trial (LIMIT-2), a clinical study investigating the effects of intravenous magnesium sulphate on 28-day mortality and morbidity in suspected AMI patients. Many LIMIT-2 subjects also received thrombolytic and anti-platelet therapy, differentiating findings of this study from earlier results. Implications for practice, education, and future research are discussed.
Fitzsimmons
L
L
San Diego State University School of Nursing, California.
Verderber
A
A
Shively
M
M
D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008278:Magnesium Sulfate / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000451:nursing / Q000503:physiopathology
D008278:Magnesium Sulfate